China Sales Center
Tel: +8657689189675
Email: tianyu@tianyupharm.com
Latin America Market
Tel: 0576-89189685
Email: ok@tianyupharm.com
Europe & North America Market
Tel: 0576-89189306
Email: hhy@tianyupharm.com
Row Market(CIS、Turkey、Africa、etc.)
Tel: 0576-89189688
Email: pb@tianyupharm.com
Securities Investment dept.
Tel: +8657689189669
Email: stock@tianyupharm.com
HR dept.
Tel: +8657684160783
Email: job@tianyupharm.com
Purchasing dept.
Tel: +8657689189703
Email: wyj@tianyupharm.com
Tianyu Shares
R&D information
●Tianyu has following 3 R&D centers with total of more than 180 chemists.
  Hangzhou R&D center,Taizhou R&D center ,and Shanghai R&D center.
● The company has 12 national invention patents and 2 PCT patents (US, Canada) up to the present.
RESEARCH & DEVELOPMENT
Tianyu Pharmaceutical emphasizes the continuous research and development of new products and new processes. Through many years of investment and development, it has attained a strong R&D capability. While building our brand's core competiveness, we have built a professional R&D team consisting of over 150 chemists with a good number of PhD and Master degrees, who inject infinite vitality into the R&D activities of Tianyu, They have become the strong driving forces of the development of our company.
Tianyu has built three R&D centers, realized a systematic research platform and established industry leadership in the level of R&D excellence. It has obtained the synthesis patents of API like Valsartan,Ezetimibe,Telmisartan and Aliskiren, and won multiple provincial- and municipal-class technology and development prizes.